Conversely, Li et al. 26 showed that albumin could be a prognostic biomarker regardless of cancer stage, and Miura et al. 20 found that preoperative albumin could predict overall survival in 556 resected NSCLC. This evidence concerns the gene ALB and non-small cell lung carcinoma.